[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-medical-research-council-mrc-small-molecule-high-throughput-screen-using-astraz-2027-01":3,"similar-medical-research-council-mrc-small-molecule-high-throughput-screen-using-astraz-2027-01":35},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":11,"deadline_note":12,"duration":13,"trl":9,"relevance":9,"why_relevant":9,"early_career":14,"consortium":15,"first_seen":16,"last_updated":9,"update_note":9,"status":17,"stages":18,"call_frequency":19,"next_call_expected":9,"source_url":7,"created_at":20,"updated_at":20,"eligible_countries":21,"description":23,"seo_summary":9,"recurring_round":14,"canonical_id":4,"links":24},"medical-research-council-mrc-small-molecule-high-throughput-screen-using-astraz-2027-01","Small Molecule High-Throughput Screen Using AstraZeneca Facilities","Medical Research Council (MRC)","https:\u002F\u002Fwww.ukri.org\u002Fopportunity\u002Fsmall-molecule-high-throughput-screen-using-astrazeneca-facilities\u002F","Up to £270,000 FEC (£250,000 cost to MRC)",null,315900,"2027-01-28T00:00:00.000Z","16:00 UK time","12-18 months (typically 15 months)",false,"Required - host research organisation with AstraZeneca providing screening facilities and technical input","2026-09-13T00:00:00.000Z","open","Single stage","Annual","2026-09-13T07:56:28.365Z",[22],"GB","Supports academic researchers (excluding international research organisations and commercial-led applications) to discover small molecule drug starting points using AstraZeneca's compound library and HTS facilities. MRC funds up to four projects per year; researchers are encouraged to embed at AstraZeneca's Cambridge site for up to three months.",{"matchedProgram":9,"resourceSlug":9,"relatedGuides":25,"countryHubs":26,"domainHubs":30,"closingMonth":31,"hasRelated":14,"hasBrowseRelated":34},[],[27],{"slug":28,"demonym":29},"gb","UK researchers",[],{"slug":32,"label":33},"2027-01","January 2027",true,{"grants":36},[37,43,47,50,56],{"id":38,"name":39,"funder":40,"deadline":41,"budget":42},"cancer-research-uk-therapeutic-catalyst-2026-09","Therapeutic Catalyst","Cancer Research UK","2026-09-25T00:00:00.000Z","Up to £250k (Target Award) or up to £350k (Early Therapy Award)",{"id":44,"name":45,"funder":40,"deadline":41,"budget":46},"cancer-research-uk-therapeutic-catalyst-early-therapy-award-2026-09","Therapeutic Catalyst - Early Therapy Award","Up to £350k",{"id":48,"name":49,"funder":40,"deadline":9,"budget":9},"cancer-research-uk-drug-development-project-2026","Drug Development Project",{"id":51,"name":52,"funder":53,"deadline":54,"budget":55},"mrc-ukri-translation-mrc-impact-acceleration-awards-2026-11","Translation MRC Impact Acceleration Awards","MRC (UKRI)","2026-11-11T00:00:00.000Z","£50k–£300k FEC (80% funded, i.e. up to £240k awarded)",{"id":57,"name":58,"funder":40,"deadline":41,"budget":59},"cancer-research-uk-therapeutic-catalyst-target-award-2026-09","Therapeutic Catalyst - Target Award","Up to £250k"]